Assessment of solvent recovery efficiency in pilot-scale pharmaceutical manufacturing units
Table Of Contents
Chapter ONE
INTRODUCTION
- 1.
- 1.1Introduction
- 2.
- 1.2Background of the Study
- 3.
- 1.3Statement of the Problem
- 4.
- 1.4Aim and Objectives of the Study
- 5.
- 1.5Research Questions
- 6.
- 1.6Research Hypotheses
- 7.
- 1.7Significance of the Study
- 8.
- 1.8Scope and Delimitation of the Study
- 9.
- 1.9Limitations of the Study
- 10.
- 1.10Organisation of the Study
- 11.
- 1.11Operational Definition of Terms
Chapter TWO
LITERATURE REVIEW
- 12.
- 2.1Conceptual Review: Solvent Recovery in Pharma Processing
- 13.
- 2.2Conceptual Review: Pilot-Scale Manufacturing Constraints
- 14.
- 2.3Conceptual Review: Energy Efficiency in Solvent Recovery Systems
- 15.
- 2.4Conceptual Review: Solvent Emission and Process Contaminants
- 16.
- 2.5Conceptual Review: Process Analytical Technology in Recovery Operations
- 17.
- 2.6Conceptual Review: Green Chemistry Principles in Pharmaceutical Solvents
- 18.
- 2.7Theoretical Framework: Process Optimization Theory
- 19.
- 2.8Theoretical Framework: Thermodynamic Efficiency Theory
- 20.
- 2.9Empirical Review: Solvent Recovery Case Studies in Pilot Plants
- 21.
- 2.10Empirical Review: Monitoring and Control in Recovery Systems
- 22.
- 2.11Empirical Review: Economic Viability of Solvent Recovery
- 23.
- 2.12Identified Gaps in the Literature
- 24.
- 2.13Conceptual Model: Relationships Between Recovery Efficiency, Energy Use, and Emissions
Chapter THREE
RESEARCH METHODOLOGY
- 25.
- 3.1Research Design: Field-Based Evaluation of Pilot-Scale Units
- 26.
- 3.2Philosophical Paradigm: Pragmatism in Industrial Chemistry Research
- 27.
- 3.3Population of the Study: Pilot-Scale Pharmaceutical Units and Solvent Streams
- 28.
- 3.4Sample Size and Sampling Technique: Stratified Sampling Across Plant Lines
- 29.
- 3.5Sources and Instruments of Data Collection: On-Site Measurements, Process Logs, and Instrument Readings
- 30.
- 3.6Validity and Reliability of Instruments: Calibration Protocols and Cross-Verification
- 31.
- 3.7Data Collection Procedures: Timeline, Plant Access, and Data Logging
- 32.
- 3.8Data Management and Quality Assurance
- 33.
- 3.9Data Analysis Methods: Descriptive Statistics, Inferential Tests, and Regression Modeling
- 34.
- 3.10Model Specification or Analytical Framework: Efficiency Index Model
- 35.
- 3.11Ethical Considerations: Safety, Confidentiality, and Compliance
Chapter FOUR
DATA PRESENTATION AND ANALYSIS
- ANALYSIS AND DISCUSSION OF FINDINGS
- 36.
- 4.1Data Presentation: Solvent Recovery Rates Across Streams
- 37.
- 4.2Descriptive Analysis of Recovery Efficiency Metrics
- 38.
- 4.3Descriptive Analysis of Energy Consumption Indicators
- 39.
- 4.4Descriptive Analysis of Emission Outputs and Waste Streams
- 40.
- 4.5Hypotheses Testing: Recovery Efficiency vs. Operational Variables
- 41.
- 4.6Hypotheses Testing: Energy Input Correlations with Recovery Yields
- 42.
- 4.7Model-Based Interpretation: Efficiency Index and Key Drivers
- 43.
- 4.8Discussion of Findings in Relation to Conceptual Frameworks and Prior Studies
Chapter FIVE
SUMMARY, CONCLUSION AND RECOMMENDATIONS
- CONCLUSION AND RECOMMENDATIONS
- 44.
- 5.1Summary of Findings
- 45.
- 5.2Conclusions
- 46.
- 5.3Contribution to Knowledge: Advancing Solvent Recovery in Pilot-Scale Pharma
- 47.
- 5.4Practical Recommendations for Industry Stakeholders
- 48.
- 5.5Suggestions for Further Studies
Thesis Abstract
Solvent use in pharmaceutical manufacturing incurs significant environmental and cost burdens, with inefficiencies in recovery processes contributing to higher emissions, solvent losses, and elevated production costs. This study addresses the persistent gap between nominal recovery targets and actual performance in pilot-scale pharmaceutical units, where variability in solvent streams, process integration, and equipment condition influence recovery efficiency. The aim is to quantify recovery performance, identify primary loss pathways, and propose empirically grounded improvements to enhance material efficiency, lower costs, and reduce environmental impact. Specific objectives are (1) to quantify solvent recovery rates for commonly used solvents (acetone, methanol, and dichloromethane) across three pilot-scale single-stage and two-stage recovery configurations; (2) to identify and rank drivers of recovery inefficiency, including process parameters, equipment fouling, and operational deviations; (3) to develop a predictive model linking process variables to recovery efficiency; (4) to evaluate the economic and environmental implications of proposed optimization strategies; and (5) to formulate actionable guidelines for scale-up to full production. A mixed-methods approach integrates quantitative process data with qualitative insights from operator interviews. The population comprises pilot-scale pharmaceutical manufacturing units located in three multi-product facilities. A purposive sample of 12 recovery trains across these facilities is selected, with 6 units employing single-stage distillation and 6 employing two-stage solvent recovery configurations. Data collection combines (i) process data logs collected over 24 weeks, including feed solvent composition, temperature, pressure, residence times, and condenser efficiencies, (ii) analytical measurements of recovered solvent by GC-FID and GC-MS to determine purity and recovery yield, and (iii) structured interviews with 18 process engineers/operators to capture tacit knowledge on operational deviations and maintenance practices. Instruments are validated through calibration standards, inter-laboratory comparisons, and pilot-test runs. Analytical methods include descriptive statistics to profile baseline recovery performance, ANOVA to compare recovery efficiency across configurations and facilities, multivariate regression to identify significant predictors of recovery yield, and a hierarchical linear model to account for nested facility effects. Process-level mass balance checks ensure data integrity, while sensitivity analyses test robustness of the predictive model under alternative scenarios. A cost-benefit analysis evaluates the economic implications by calculating savings from solvent recovery improvements using net present value (NPV) and return on investment (ROI) over a 5-year horizon. Environmental performance is assessed via solvent emission reductions and life-cycle impact indicators. Expected findings include statistically significant differences in recovery efficiency between single-stage and two-stage configurations, with two-stage systems achieving up to 15–22% higher overall recovery yields under typical feed compositions. Key drivers of inefficiency are anticipated to be condenser fouling, suboptimal reflux ratios, and inconsistencies in feed solvent ratios due to upstream process variability. The predictive model is expected to explain a substantial portion of variance (R-squared > 0.70) in recovery yield when incorporating solvent characteristics, feed flow rate, and equipment condition indicators. The study also anticipates a favorable economic signal, with estimated payback periods within 2–4 years for recommended optimizations, driven by solvent savings and reduced waste disposal costs, and a measurable reduction in volatile organic compound (VOC) emissions. The contribution to knowledge lies in providing a rigorous empirical assessment of solvent recovery performance at the pilot scale, quantifying inefficient pathways, and delivering a validated predictive framework to inform design and operation of recovery systems in pharmaceutical pilot plants. The study advances understanding of how process design choices and operational practices interact to determine recovery outcomes and offers evidence-based guidelines for improving solvent efficiency during scale-up. The main conclusion is that optimization of recovery configuration, systematic maintenance to control condenser performance, and active feed quality management can substantially elevate recovery efficiency, reduce costs, and lower environmental impact. Recommendations include adopting two-stage recovery with calibrated reflux control, implementing a preventive maintenance program focused on condenser cleanliness, and integrating the predictive model into plant digital twins to guide real-time operational decisions.
Thesis Overview
This research investigates how efficiently solvents are recovered in pilot-scale pharmaceutical manufacturing units, where large amounts of solvents are used for reactions, extractions, and cleaning. The goal is to quantify recovery rates, identify losses, and understand how recovery performance affects cost, environmental impact, and process sustainability. The study addresses a practical gap: while laboratory and full-scale data exist, there is limited understanding of solvent recovery behavior at pilot scale, where process conditions and equipment configurations differ from both bench and industrial scales.
What the researcher will do
- Define the scope: select a representative pilot-scale pharmaceutical unit with common solvents such as acetonitrile, methanol, and ethyl acetate.
- Data collection plan:
- Gather process data over six to twelve months, including solvent input/consumption, recovered solvent volumes, losses to waste, energy usage, and operating conditions.
- Conduct targeted measurements using gas chromatography (GC) and high-performance liquid chromatography (HPLC) to quantify solvent purity in recovered streams.
- Record process parameters (temperatures, pressures, timestamps) and equipment configuration for each recovery stage.
- Interview operators to capture routine practices, maintenance schedules, and material balances.
- Data analysis:
- Perform material balance calculations to determine recovery efficiency for each solvent.
- Use regression analysis to relate recovery efficiency to process variables (temperature, residence time, and equipment type).
- Apply ANOVA to assess differences across solvent types and equipment configurations.
- Develop a conceptual model linking process design, operating conditions, and recovery outcomes.
- Validation: compare pilot-scale findings with available literature for similar systems and, where feasible, a small-scale validation run.
What contribution the study will make
- Provide empirical benchmarks for solvent recovery efficiency at pilot scale, enabling better process design and decision-making.
- Identify key factors driving losses and opportunities for improvement, including equipment modifications, process controls, and maintenance practices.
- Support environmental and economic assessments by reducing solvent waste and energy use, informing sustainability strategies in pharmaceutical manufacturing.
Expected outcomes
- Quantified recovery efficiencies for major solvents, with identified sensitivities to operating conditions.
- A practical framework and set of recommendations for optimizing solvent recovery at pilot scale, including process control strategies and cost-benefit considerations.